Ticker > Company >

Jeevan Scientific share price

Jeevan Scientific Technology Ltd.

BSE: 538837 SECTOR: IT - Software  20.52 K   47   3

60.00
-2.83 (-4.50%)
BSE: 07 Nov 04:01 PM

Price Summary

Today's High

₹ 62.99

Today's Low

₹ 60

52 Week High

₹ 66.9

52 Week Low

₹ 32.85

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

95 Cr.

Enterprise Value

103.04 Cr.

No. of Shares

1.58 Cr.

P/E

0

P/B

2.22

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  26.98

CASH

0.21 Cr.

DEBT

8.25 Cr.

Promoter Holding

38.05 %

EPS (TTM)

₹  -1.91

Sales Growth

13.27%

ROE

1.66 %

ROCE

3.48%

Profit Growth

170.09 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.27%
3 Year-8.3%
5 Year16.22%

Profit Growth

1 Year170.09%
3 Year-60.85%
5 Year15.93%

ROE%

1 Year1.66%
3 Year-2.39%
5 Year11.75%

ROCE %

1 Year3.48%
3 Year-0.6%
5 Year13.41%

Debt/Equity

0.1837

Price to Cash Flow

32.11

Interest Cover Ratio

1.6531

CFO/PAT (5 Yr. Avg.)

1.17321521367944

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 38.05 0.00
Jun 2025 38.05 0.00
Mar 2025 38.05 0.00
Dec 2024 37.84 0.00
Sep 2024 38.70 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has effective cash conversion ratio of 402.134022019845.
  • Company has sound operating leverage of 18.7839997421002 times.

 Limitations

  • Company has a poor ROE (Return on Equity) track record: 3 Years’ ROE -2.3939%.
  • The company has delivered poor profit growth of -60.8527424941565% over past 3 years.
  • The company has delivered poor Income growth of -8.29951823183143% over past 3 years.
  • The company has been maintaining a poor ROCE of -0.5976% since last 3 years.
  • The company has been maintaining poor Dividend Payout ratio of 0% since last 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 12.52 10.3 11.87 8.93 8.22
Total Expenditure 9.13 8.36 9.83 9.84 9.33
Operating Profit 3.39 1.94 2.04 -0.91 -1.11
Other Income 0.11 0.16 0.22 0.14 0.38
Interest 0.15 0.27 0.26 0.35 0.36
Depreciation 1.28 1.25 1.23 1.53 1.5
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.07 0.58 0.77 -2.65 -2.59
Tax 0.47 0.44 0.44 -1.31 -0.43
Profit After Tax 1.6 0.15 0.32 -1.34 -2.16
Adjusted EPS (Rs) 1.03 0.1 0.2 -0.85 -1.36

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 40.47 56.55 36.18 38.5 43.61
Total Expenditure 23.85 39.48 34.82 34.09 37.02
Operating Profit 16.62 17.07 1.35 4.41 6.59
Other Income 2.4 5.92 1.06 0.69 0.65
Interest 1.88 0.96 1.01 0.78 1.18
Depreciation 3.96 3.68 5.02 5.55 5.29
Exceptional Items 0 0 0 0 0
Profit Before Tax 13.18 18.35 -3.62 -1.23 0.77
Provision for Tax 1.92 6.09 -0.62 -0.18 0.03
Net Profit 11.26 12.26 -3 -1.05 0.74
Adjusted EPS (Rs.) 7.36 8.01 -1.94 -0.68 0.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 15.3 15.3 15.48 15.48 15.83
Total Reserves 20.95 35.28 32.84 33.32 35.08
Borrowings 7.77 4.23 3.21 1.77 6.02
Other N/C liabilities -0.29 0.78 1.15 0.36 3.14
Current liabilities 19.44 22.29 10.44 8.17 9.76
Total Liabilities 63.17 77.88 63.12 59.1 69.84
Assets
Net Block 16.36 19.07 24.03 20.2 28.72
Capital WIP 0 0 0 0 0
Intangible WIP 4.16 0 0 0 0
Investments 1.03 0 2 2 2
Loans & Advances 10.66 4.87 9.14 12.67 9.2
Other N/C Assets 0 0.06 0 0 0
Current Assets 30.96 53.89 27.95 24.23 29.91
Total Assets 63.17 77.88 63.12 59.1 69.84
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 13.18 18.35 -3.62 -1.23 0.77
Adjustment 5.73 4.6 7.45 7.1 6.7
Changes in Assets & Liabilities -10.54 2.7 -7.37 -1.36 -4.63
Tax Paid -1.92 -6.09 -2.75 -1.77 0.12
Operating Cash Flow 4.73 19.56 -6.29 2.74 2.96
Investing Cash Flow -0.8 -1.2 -7.27 -4.69 -9.84
Financing Cash Flow -0.13 5.67 -10.03 -3.66 6.58
Net Cash Flow 3.8 24.03 -23.59 -5.61 -0.3

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 38.70 37.84 38.05 38.05 38.05
gopi krishna kilaru 4.65 4.55 4.55 4.55 4.55
jeevan krishna kuchipudi 5.71 5.58 5.80 5.80 5.80
jeevan mitra chit fund pr... 0.55 0.54 0.54 0.54 0.54
k krishna kishore 1.29 1.26 1.26 1.26 1.26
k vanaja 10.17 9.94 9.94 9.94 9.94
krishna kishore kuchipudi... 12.50 12.22 12.22 12.22 12.22
ravi thammareddy . - - - - 2.48
snigdha mothukuri 0.51 0.50 0.50 0.50 0.50
sridevi thammareddy 0.78 0.76 0.76 0.76 0.76
ravi thammareddy 2.54 2.48 2.48 2.48 -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 61.30 62.16 61.95 61.95 61.95
akhila kakarala 1.29 1.26 1.26 1.26 1.26
devi charan gamini 1.10 1.07 1.08 1.10 1.10
dheeraj kumar lohia 3.41 3.35 3.35 3.35 3.35
durisala desaiah 5.36 - 5.24 5.24 5.24
nandela gopalakrishna red... 3.23 - 3.16 3.16 3.16
radhika rampa 3.23 3.16 3.16 3.16 3.16
ramakrishna prasad kakara... 1.74 1.70 1.70 1.70 1.70
vidyullatha kodali 1.94 1.89 1.89 1.89 1.89
yarlagadda nageshwara rao... - - - 1.45 1.45
nageswara rao yarllagadda... - 1.45 1.45 - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Jeevan Scientific Technology informs about EGM 18 Oct, 3:05 PM Jeevan Scientific - Quaterly Results 14 Aug, 5:54 PM Jeevan Scientific - Quaterly Results 14 Aug, 5:54 PM Jeevan Scientific Technology informs about newspaper cuttings 31 May, 3:14 PM Jeevan Scientific Technology informs about disclosure 26 Mar, 10:56 AM Jeevan Scientific Technology informs about disclosures 17 Mar, 3:04 PM Jeevan Scientific Technology informs about disclosure 17 Mar, 1:25 PM Jeevan Scientific - Quaterly Results 6 Feb, 7:13 PM Jeevan Scientific - Quaterly Results 6 Feb, 7:13 PM Jeevan Scientific - Quaterly Results 8 Nov, 3:42 PM Jeevan Scientific - Quaterly Results 8 Nov, 3:42 PM Jeevan Scientific - Quaterly Results 8 Nov, 3:42 PM Jeevan Scientific Technology submits copy of newspaper cuttings 10 Aug, 12:15 PM Jeevan Scientific - Quaterly Results 9 Aug, 1:55 PM Jeevan Scientific - Quaterly Results 9 Aug, 1:55 PM Jeevan Scientific - Quaterly Results 9 Aug, 1:55 PM USFDA inspects Jeevan Scientific Technology’s Bioanalytical Facility in Hyderabad 23 Feb, 6:16 PM Jeevan Scientific - Quaterly Results 14 Feb, 5:24 PM Jeevan Scientific - Quaterly Results 14 Feb, 5:24 PM Jeevan Scientific Technology’s arm inks agreement with Aditri Pharma Sciences 18 Oct, 5:31 PM Jeevan Scientific Technology informs about compliance certificate 16 Oct, 5:11 PM Jeevan Scientific - Quaterly Results 14 Aug, 1:31 PM Jeevan Scientific Technology informs about disclosure 22 Mar, 4:13 PM WHO completes inspection at JSTL’s Hyderabad facility, Centre with ‘No Critical Observations’ 18 Mar, 11:54 AM USFDA conducts inspection at JSTL’s clinical pharmacology centre in Hyderabad 6 Mar, 4:14 PM Jeevan Scientific Technology informs about disclosure 2 Mar, 4:51 PM Jeevan Scientific Technology informs about unaudited financial results 8 Feb, 5:13 PM Jeevan Scientific - Quaterly Results 8 Feb, 2:32 PM Jeevan Scientific - Quaterly Results 8 Feb, 2:32 PM Jeevan Scientific - Quaterly Results 8 Feb, 2:32 PM Jeevan Scientific Technology informs about loss of share certificate 1 Dec, 4:58 PM Jeevan Scientific Technology informs about disclosure 1 Dec, 4:26 PM USFDA conducts inspection of Jeevan Scientific Technology’s facility 17 Jun, 6:01 PM Jeevan Scientific Technology informs about disclosure 9 Jun, 4:53 PM Jeevan Scientific Technology informs about outcome of board meeting 8 Jun, 4:52 PM Jeevan Scientific Technology informs about newspaper clippings 1 Jun, 3:23 PM Jeevan Scientific Technology informs about board meeting 19 May, 4:37 PM Jeevan Scientific Technology informs about loss of share certificate 23 Apr, 5:13 PM Jeevan Scientific Technology informs about board meeting 19 Mar, 4:46 PM Jeevan Scientific Technology informs about disclosure 7 Mar, 3:50 PM Jeevan Scientific Technology informs about details of loss of share certificate 15 Feb, 4:41 PM Jeevan Scientific Technology informs about board meeting 3 Feb, 4:40 PM Jeevan Scientific Technology informs about related party transactions 29 Nov, 3:51 PM Jeevan Scientific Technology informs about board meeting 22 Nov, 2:16 PM Jeevan Scientific Technology informs about certificate 20 Oct, 10:44 AM Jeevan Scientific Technology informs about newspaper publication 25 Aug, 2:11 PM Jeevan Scientific Technology informs about record date 10 Aug, 12:13 PM Jeevan Scientific Technology informs about book closure 10 Aug, 12:10 PM Jeevan Scientific Technology informs about certificate 12 May, 10:30 AM Jeevan Scientific Technology informs about certificate 21 Jan, 3:49 PM

Jeevan Scientific Stock Price Analysis and Quick Research Report. Is Jeevan Scientific an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Jeevan Scientific. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Jeevan Scientific has a PE ratio of -31.3856776690903 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Jeevan Scientific has ROA of 1.1412% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Jeevan Scientific has a Current ratio of 3.0653.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Jeevan Scientific has a ROE of 1.659%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Jeevan Scientific has a Debt to Equity ratio of 0.1837 which means that the company has low proportion of debt in its capital.

  • Sales growth: Jeevan Scientific has reported revenue growth of 13.2675% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Jeevan Scientific for the current financial year is 15.1036805862889%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Jeevan Scientific is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Jeevan Scientific is Rs -1.9117. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Jeevan Scientific in Ticker for free. Also, one can get the intrinsic value of Jeevan Scientific by using Valuation Calculators, which are available with a Finology ONE subscription. 

Jeevan Scientific FAQs

Q1. What is Jeevan Scientific share price today?
Ans: The current share price of Jeevan Scientific is Rs 60.

Q2. What is the market capitalisation of Jeevan Scientific?
Ans: Jeevan Scientific has a market capitalisation of Rs 95.00379 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Jeevan Scientific?
Ans: The PE ratio of Jeevan Scientific is -31.3856776690903 and the P/B ratio of Jeevan Scientific is 2.2237458999685, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Jeevan Scientific share?
Ans: The 52-week high share price of Jeevan Scientific is Rs 66.9, and the 52-week low share price of Jeevan Scientific is Rs 32.85.

Q5. Does Jeevan Scientific pay dividends?
Ans: Currently, Jeevan Scientific does not pay dividends. Dividend yield of Jeevan Scientific is around 0%.

Q6. What are the face value and book value of Jeevan Scientific shares?
Ans: The face value of Jeevan Scientific shares is Rs 10, while the book value per share of Jeevan Scientific is around Rs 26.9815. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Jeevan Scientific?
Ans: Jeevan Scientific has a total debt of Rs 8.2469 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Jeevan Scientific?
Ans: The ROE of Jeevan Scientific is 1.659% and ROCE of Jeevan Scientific is 3.4761%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Jeevan Scientific a good buy for the long term?
Ans: The Jeevan Scientific long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Jeevan Scientific undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Jeevan Scientific appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Jeevan Scientific’s financials?
Ans: You can review Jeevan Scientific’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Jeevan Scientific
X